| 摘要 |
<p>The application relates to novel heterocyclic compounds of the general formula (I) and salts, preferably pharmaceutically acceptable salts, thereof, in which R, R<SUP>1</SUP>, R<SUP>2</SUP>, R<SUP>3</SUP>, Q, m and n have the meanings explained in detail in the description, and * designates an asymmetric carbon atom, a process for their preparation and the use of these compounds as medicaments, in particular as aromatase inhibitors.</p> |
